Miller JD

No ORCID on file · 9 papers in corpus · active 1990-2014

Study types

  • article 7
  • rct 1

Condition tags

  • endometriosis 8
2014
Retrospective database analysis of clinical outcomes and costs for treatment of abnormal uterine bleeding among women enrolled in US Medicaid programs.
ClinicoEconomics and outcomes research : CEOR ·doi:10.2147/ceor.s67888

BackgroundWomen with abnormal uterine bleeding (AUB) may be treated surgically with hysterectomy or global endometrial ablation (GEA), an outpatient procedure. We compared the costs and clinical outcomes of these surgical procedures for AUB…

article 2000
Quantification of endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy: A double-blind, randomized, placebo-controlled trial
American Journal of Obstetrics and Gynecology ·doi:10.1067/mob.2000.106846

ObjectiveThe purpose of this study was a quantification of changes in endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy.Study designOne hundred twenty women with…

article 1998
Historical prospective cohort study of the recurrence of pain after discontinuation of treatment with danazol or a gonadotropin- releasing hormone agonist
Fertility and Sterility ·doi:10.1016/s0015-0282(98)00166-6

ObjectiveTo determine the duration of time to the recurrence of pain attributable to endometriosis after the discontinuation of treatment with danazol or a GnRH agonist (GnRH-a) in patients who have had a satisfactory response to the treatm…

article 1997
Therapeutic effects of leuprorelin microspheres on endometriosis and uterine leiomyomata
Advanced drug delivery reviews ·doi:10.1016/s0169-409x(97)00055-0

Uterine leiomyomata and endometriosis are two common hormone-dependent pathologies effecting women of reproductive age. Prior to the introduction of gonadotropin releasing hormone agonists (GnRHa), there was no effective medical therapy for…

rct 1993
Depot leuprolide acetate versus danazol in the treatment of women with symptomatic endometriosis: a multicenter, double-blind randomized clinical trial. II. Assessment of safety. The Lupron Endometriosis Study Group
American Journal of Obstetrics and Gynecology ·doi:10.1016/0002-9378(93)90126-4

OBJECTIVES: This is the first multicenter, double-blind randomized clinical trial that compares a depot gonadotropin-releasing hormone agonist with danazol in the treatment of endometriosis. Efficacy results have been previously reported; t…

article 1992
Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis
American Journal of Obstetrics and Gynecology ·doi:10.1016/s0002-9378(11)91718-9

ObjectiveWe aimed to assess the efficacy of depot leuprolide versus danazol in the treatment of endometriosis.Study designA double-blind randomized trial of 270 patients from 22 centers compared the pretreatment and posttreatment laparoscop…

article 1990
Leuprolide acetate for the treatment of endometriosis.
Progress in clinical and biological research
article 1990
Leuprolide acetate in the management of ureteral obstruction caused by endometriosis.
Obstetrics and gynecology

Endometriotic ureteral obstruction is a serious event commonly diagnosed late and therefore associated with a major risk of hydronephrotic renal atrophy. The standard therapy is surgical. However, medical treatment has been reported using d…

article 1990
Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study
Fertility and Sterility ·doi:10.1016/s0015-0282(16)53755-8

The safety and efficacy of leuprolide acetate (LA) for depot suspension (Lupron depot; TAP Pharmaceuticals, North Chicago, IL), 3.75 mg versus placebo, in the treatment of pain associated with endometriosis was assessed in a randomized, dou…